Clinical Trial Update: Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL [Phase 2]

View source ↗

Summary

Phase II study evaluating age-adjusted rituximab, bendamustine, and cytarabine as induction therapy in older patients with mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• CYTARABINE (CYTARABINE)
• Rituximab (rituximab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED